ОТЧËТ $MNK — Mallinckrodt
Прибыль на акцию: 1.89/ 1.35$ (ожидания)
Выручка: 700 / 632.4 M (ожидания)
Second quarter net sales of $166.5 million net of the retrospective one-time Acthar Gel Medicaid liability adjusted net sales of $700.9 million, a decline of 14.9, due primarily to demand impacts related to COVID-19 and competitive and payer pressures on certain products
Diluted loss per share of $11.04 with adjusted diluted earnings per share (EPS) of $1.89, a decline of 25.3
Operating cash flows of $170.9 million in the quarter with free cash flow of $159.5 million
GIPHY App Key not set. Please check settings